Overview Dividends

(ENSG) The Ensign - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US29358P1012

Skilled Nursing, Senior Living, Rehabilitative Services, Property Leasing, Ancillary Services

ENSG EPS (Earnings per Share)

EPS Growth (3Y CAGR): 15.63%
EPS Trend (3Y Correlation): 97.0%

ENSG Revenue

Revenue Growth (3Y CAGR): 18.68%
Revenue Trend (3Y Correlation): 99.4%

Description: ENSG The Ensign November 04, 2025

The Ensign Group, Inc. (NASDAQ: ENSG) operates a diversified portfolio of post-acute and senior-living services across 15 U.S. states. Its business is split between the Skilled Services segment-delivering short- and long-term nursing care, specialty programs (dialysis, ventilator, cardiac, pulmonary), and ancillary diagnostics-and the Standard Bearer segment, which owns and leases post-acute care facilities to third-party operators while also managing senior-living units.

Key operating metrics that investors monitor include an average occupancy rate of roughly 84% across its skilled-nursing facilities (FY 2023) and a revenue growth rate of 6.2% year-over-year, driven in part by rising demand for chronic-care beds as the U.S. population ages. The sector’s profitability is tightly linked to Medicare and Medicaid reimbursement trends; recent CMS policy updates that increase per-day rates for high-complexity cases have bolstered ENSG’s margin outlook, with FY 2023 EBITDA margin reported at 12.5%.

For a deeper quantitative view of ENSG’s valuation metrics, you may find the ValueRay platform’s analyst toolkit useful.

ENSG Stock Overview

Market Cap in USD	10,657m
Sub-Industry	Health Care Facilities
IPO / Inception	2007-11-09

ENSG Stock Ratings

Growth Rating	86.1%
Fundamental	80.7%
Dividend Rating	50.3%
Return 12m vs S&P 500	6.43%
Analyst Rating	4.50 of 5

ENSG Dividends

Dividend Yield 12m	0.14%
Yield on Cost 5y	0.40%
Annual Growth 5y	4.62%
Payout Consistency	98.6%
Payout Ratio	4.1%

ENSG Growth Ratios

Growth Correlation 3m	83.6%
Growth Correlation 12m	70.7%
Growth Correlation 5y	91.6%
CAGR 5y	25.44%
CAGR/Max DD 3y (Calmar Ratio)	1.08
CAGR/Mean DD 3y (Pain Ratio)	4.43
Sharpe Ratio 12m	1.14
Alpha	0.76
Beta	0.928
Volatility	32.28%
Current Volume	699k
Average Volume 20d	389.7k
Stop Loss	174.5 (-3%)
Signal	-0.99

Piotroski VR‑10 (Strict, 0-10) 8.0

Net Income (328.2m TTM) > 0 and > 6% of Revenue (6% = 289.8m TTM)

FCFTA 0.06 (>2.0%) and ΔFCFTA 1.37pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 7.90% (prev 10.42%; Δ -2.52pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.09 (>3.0%) and CFO 481.4m > Net Income 328.2m (YES >=105%, WARN >=100%)

Net Debt (1.57b) to EBITDA (538.7m) ratio: 2.92 <= 3.0 (WARN <= 3.5)

Current Ratio 1.46 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (59.0m) change vs 12m ago 0.88% (target <= -2.0% for YES)

Gross Margin 15.65% (prev 15.51%; Δ 0.14pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 98.00% (prev 88.76%; Δ 9.25pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 53.02 (EBITDA TTM 538.7m / Interest Expense TTM 8.29m) >= 6 (WARN >= 3)

Altman Z'' 2.68

(A) 0.07 = (Total Current Assets 1.21b - Total Current Liabilities 825.2m) / Total Assets 5.23b

(B) 0.32 = Retained Earnings (Balance) 1.66b / Total Assets 5.23b

(D) 0.54 = Book Value of Equity 1.66b / Total Liabilities 3.10b

Total Rating: 2.68 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 80.74

1. Piotroski 8.0pt = 3.0

2. FCF Yield 2.38% = 1.19

3. FCF Margin 6.00% = 1.50

4. Debt/Equity 0.95 = 2.07

5. Debt/Ebitda 2.92 = -1.66

6. ROIC - WACC (= 8.76)% = 10.95

7. RoE 16.62% = 1.38

8. Rev. Trend 99.39% = 7.45

9. EPS Trend 97.03% = 4.85

What is the price of ENSG shares?

As of November 08, 2025, the stock is trading at USD 179.97 with a total of 698,965 shares traded.
Over the past week, the price has changed by -0.07%, over one month by +1.97%, over three months by +13.05% and over the past year by +21.35%.

Is The Ensign a good stock to buy?

Yes, based on ValueRay´s Fundamental Analyses, The Ensign (NASDAQ:ENSG) is currently (November 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 80.74 and therefor a positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ENSG is around 197.50 USD . This means that ENSG is currently overvalued and has a potential downside of 9.74%.

Is ENSG a buy, sell or hold?

The Ensign has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy ENSG.

Strong Buy: 4
Buy: 1
Hold: 1
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the ENSG price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	185.4	3%
Analysts Target Price	185.4	3%
ValueRay Target Price	219.1	21.7%

ENSG Fundamental Data Overview November 06, 2025

Market Cap USD = 10.66b (10.66b USD * 1.0 USD.USD)
P/E Trailing = 33.3297
P/E Forward = 23.5849
P/S = 2.3093
P/B = 4.974
P/EG = 1.5727
Beta = 0.928
Revenue TTM = 4.83b USD
EBIT TTM = 439.6m USD
EBITDA TTM = 538.7m USD
Long Term Debt = 141.6m USD (from longTermDebt, last fiscal year)
Short Term Debt = 115.0m USD (from shortTermDebt, last quarter)
Debt = 2.02b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.57b USD (from netDebt column, last quarter)
Enterprise Value = 12.17b USD (10.66b + Debt 2.02b - CCE 506.3m)
Interest Coverage Ratio = 53.02 (Ebit TTM 439.6m / Interest Expense TTM 8.29m)
FCF Yield = 2.38% (FCF TTM 289.5m / Enterprise Value 12.17b)
FCF Margin = 6.00% (FCF TTM 289.5m / Revenue TTM 4.83b)
Net Margin = 6.80% (Net Income TTM 328.2m / Revenue TTM 4.83b)
Gross Margin = 15.65% ((Revenue TTM 4.83b - Cost of Revenue TTM 4.07b) / Revenue TTM)
Gross Margin QoQ = 14.67% (prev 16.19%)
Tobins Q-Ratio = 2.33 (Enterprise Value 12.17b / Total Assets 5.23b)
Interest Expense / Debt = 0.10% (Interest Expense 1.97m / Debt 2.02b)
Taxrate = 21.28% (22.7m / 106.6m)
NOPAT = 346.0m (EBIT 439.6m * (1 - 21.28%))
Current Ratio = 1.46 (Total Current Assets 1.21b / Total Current Liabilities 825.2m)
Debt / Equity = 0.95 (Debt 2.02b / totalStockholderEquity, last quarter 2.12b)
Debt / EBITDA = 2.92 (Net Debt 1.57b / EBITDA 538.7m)
Debt / FCF = 5.44 (Net Debt 1.57b / FCF TTM 289.5m)
Total Stockholder Equity = 1.98b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.28% (Net Income 328.2m / Total Assets 5.23b)
RoE = 16.62% (Net Income TTM 328.2m / Total Stockholder Equity 1.98b)
RoCE = 20.77% (EBIT 439.6m / Capital Employed (Equity 1.98b + L.T.Debt 141.6m))
RoIC = 16.70% (NOPAT 346.0m / Invested Capital 2.07b)
WACC = 7.94% (E(10.66b)/V(12.67b) * Re(9.43%) + D(2.02b)/V(12.67b) * Rd(0.10%) * (1-Tc(0.21)))
Discount Rate = 9.43% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.21%
[DCF Debug] Terminal Value 72.69% ; FCFE base≈251.0m ; Y1≈241.3m ; Y5≈236.7m
Fair Price DCF = 57.38 (DCF Value 3.32b / Shares Outstanding 57.9m; 5y FCF grow -5.16% → 3.0% )
EPS Correlation: 97.03 | EPS CAGR: 15.63% | SUE: 0.61 | # QB: 0
Revenue Correlation: 99.39 | Revenue CAGR: 18.68% | SUE: 3.37 | # QB: 2

Additional Sources for ENSG Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle